Order Entry
Austria
ContactUsLinkComponent
 
Human recombinant BCMA (from HEK293)
 
Human recombinant BCMA (from HEK293)

 

  • Konjugation:
    Unconjugated
  • Protein/Peptid-Typ:
    Rekombinant
  • Ursprung:
    HEK293 cells
  • Spezies:
    Human
  • Lagerbedingungen:
    –20 °C
  • Endotoxingehalt:
    Less than 0,01 EU per μg by the LAL method.
  • Biologische Aktivität:
    Lyophilised from 0,22 μm filtered solution in 50 mM Tris, 100 mM Glycine, 150 mM NaCl, pH 7,5. Normally trehalose is added as protectant before lyophilisation. Measured by its binding ability in a functional ELISA. Immobilised Human BAFF, His Tag (Cat. No. BAF-H5248) at 5 μg/ml (100 μl/well) can bind Human BCMA, Llama IgG2b Fc Tag (Cat. No. BCA-H5259) with a linear range of 0,02 - 0,4 ng/ml (QC tested). Measured by its binding ability in a functional ELISA. Immobilised Human BCMA, Llama IgG2b Fc Tag (Cat. No. BCA-H5259) at 2 μg/ml (100 μl/well) can bind Anti-Human BCMA Mab with a linear range of 0,4 - 3 ng/ml (Routinely tested).
  • Gen-ID:
    Q02223-1
  • Frei von Trägern:
    Y
  • Frei von Proteasen:
    Y
  • Tierfrei:
    Y
  • Proteinsynonym:
    CD269|TNFRSF17|BCM
  • Protein/Peptid-Name:
    BCMA
  • Purity:
    >90%
  • Molecular weight:
    33,7 kDa
  • Endotoxinspiegel:
    Low
  • Zusammensetzung:
    Lyophilised from 0,22 μm filtered solution in 50 mM Tris, 100 mM Glycine, 150 mM NaCl, pH 7,5. Normally trehalose is added as protectant before lyophilisation.
  • Frei von Nukleasen:
    Y
  • Transporttemperatur:
    Powder, RT

 

Frequently Bought Together